FibroBiologics goes public through direct listing on Nasdaq (NASDAQ:FBLG)
2d illustrations and photos/iStock via Getty Images FibroBiologics (NASDAQ:FBLG), which is developing a treatment for multiple sclerosis, made its market…
2d illustrations and photos/iStock via Getty Images FibroBiologics (NASDAQ:FBLG), which is developing a treatment for multiple sclerosis, made its market…